ArticleCancer science2024

Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.

Teresa Pacifico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.